Overall, researchers have hypothesised that this polymorphism might alter the effect of the TME on IL6 expression: while wild-type tumours increase production of the cytokine in response of inflammatory stimuli such as radio- or chemotherapy or in ER- disease, mutant tumours might produce more IL6 regardless of systemic changes [239]. This evidence concerns the gene IL6 and neoplasm.